Market Overview

Mirum Pharmaceuticals, Inc. - common stock (MIRM)

25.28 +1.77 (7.53%)

Analyst Ratings

DateResearch FirmActionCurrentPT
8/07/20Raymond JamesUpgradesStrong Buy48.0
8/03/20HC Wainwright & Co.Initiates Coverage OnBuy52.0
7/31/20Piper SandlerInitiates Coverage OnOverweight77.0
6/25/20BairdInitiates Coverage OnOutperform30.0
5/08/20Raymond JamesReiteratesOutperform28.0
8/12/19Roth CapitalInitiates Coverage OnBuy33.0
8/12/19GuggenheimInitiates Coverage OnBuy
8/12/19CitigroupInitiates Coverage OnBuy21.0
8/12/19Raymond JamesInitiates Coverage OnOutperform28.0
8/12/19Evercore ISI GroupInitiates Coverage OnOutperform

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter